Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6.
about
Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted TissuesBovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cellsDecreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.Role of CD40 ligation in dendritic cell semimaturationHIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cellsHelminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cellsDefining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.Pro-inflammatory, Th1, Th2, Th17 cytokines and dendritic cells: a cross-sectional study in chronic periodontitis.Dynamic changes of DC and T cell subsets in mice during Echinococcus multilocularis infection.Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis.LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.A Lectin-EGF antibody promotes regulatory T cells and attenuates nephrotoxic nephritis via DC-SIGN on dendritic cellsMycobacterial and mouse HSP70 have immuno-modulatory effects on dendritic cells.New insights into the molecular pathogenesis of langerhans cell histiocytosis.Neuroendocrine cancer vaccines in clinical trials.Mycobacterium avium subspecies impair dendritic cell maturation.Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.Therapeutic potential of semi-mature dendritic cells for tolerance induction.Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence.Repulsive guidance molecule a blockade exerts the immunoregulatory function in DCs stimulated with ABP and LPSChanges in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune ActivationTargeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.Repeated ultraviolet irradiation induces the expression of Toll-like receptor 4, IL-6, and IL-10 in neonatal human melanocytes.Induction of human tolerogenic dendritic cells by 3'-sialyllactose via TLR4 is explained by LPS contamination.Augmenting endogenous repair of soft tissues with nanofibre scaffolds.Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses
P2860
Q26797410-BB7696DA-9D50-470D-863A-7592206819F3Q28742177-CF858DD1-6D37-4BA5-AA52-7C9EF5415E1DQ33403052-7B5E9BB7-9F8E-456D-BD82-51F2344A6391Q33968156-0C33CFF6-CD86-4007-BAE1-6F804FD77722Q34248435-25794181-A761-41F3-84C5-BD4E6D85E1EEQ34261887-B7A219D8-7DA3-454E-9C08-ADDADB447982Q34357885-84857A8C-E136-43F6-9DF8-400CD1AE6904Q34438000-BB3B34CE-4677-44DF-8710-D1AA11386324Q34512293-A0CE899C-C14B-46FD-8CCE-28F4FFC717CCQ35132041-2040B467-718E-42BA-9C04-2CACFE44D7C8Q35631744-2E166370-9947-4A16-84A6-93E0C6B8E72FQ35845442-5926CC0F-76AB-4DFC-85D3-3272D29C5DBCQ36574105-8AFE64C6-84CD-422B-973F-21700CA111F0Q36596819-A0AF7D4A-15CD-4739-9DD0-088E18B9FAB9Q36835243-B4FFB98D-CEC6-45C9-9038-26E5AA36B18AQ36927314-9CD5E210-DB4B-4759-B4AA-C4CEFFBAA5DEQ37589059-752F2608-276E-4DE0-8486-93D71EBE6E20Q37892589-DABE8473-0055-4682-B135-19914014A674Q39217556-8B645034-FFA9-4C45-99DF-E6172D793967Q39327060-4A23A161-CD81-452F-876A-EA4EF3668292Q39520906-633BE9AF-4814-4262-ABC8-0B87B2F2E60DQ39613283-B6301E4A-2483-4DFB-811A-F86079E9731CQ40598097-04F8AE9A-AB9E-49DA-9F54-0FDB53C56A26Q41369735-C8326475-3AB1-434B-B42E-86C7AB10E1FFQ41665214-2A7C3EE1-69F1-45A3-8586-EDA7700D1882Q41915647-BB8C3342-4B9F-4280-9DD1-0E9BCB045D8BQ48140440-3AE1C9A2-F100-4939-9267-A46E14BF68F7Q49557750-9E619DC9-A083-4639-88C3-CFAD22B81608Q52562898-42C6810E-0255-4FCE-88E2-D006297DDB53Q58662838-BD63A4E1-494A-4E0A-9892-7DC5D766928B
P2860
Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@en
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@nl
type
label
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@en
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@nl
prefLabel
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@en
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@nl
P2093
P1476
Immunomodulation by semi-matur ...... e receptors and interleukin-6.
@en
P2093
Frank Grünebach
Ingo B Autenrieth
Julia-Stefanie Frick
P356
10.1016/J.IJMM.2009.08.010
P577
2009-09-24T00:00:00Z